🔗 Share this article

An underground market for unlicensed weight-loss medications is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are urged to message these accounts directly for source information, while also receiving promotional offers.

Active Commerce on Social Networks

Additionally, a flourishing market exists on Telegram, where communities with thousands of members share comparison photos, injection guides and assertions of rapid British shipping. Vendors market the drug there before directing customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is worrisome and could lead to users injecting products of unknown origin.

Some experts said the demand for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, potentially leading to fines, prosecution or prison.

Platform Reaction and Material Removal

Based on the social media company, the service has removed problematic content and banned associated hashtags and search suggestions. The company said it was dedicated to maintaining the platform safe and allocating resources in enhancing compliance measures.

Online Trading Operations

Investigations also found communities with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, filled with photos of slimming results, glowing testimonials and detailed guides for preparing or administering at home.

Within minutes of entering one group, a seller shared WhatsApp details, where the majority of transactions occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Item Details and Costs

Within these groups, posts display dark colored packages with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually priced at £160 for 20 milligrams. When questioned how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Safety Measures

A representative for the messaging service stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they can’t verify. Although the research behind this drug is sound, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has previously seen individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose users to possibly serious health risks”.